N	Concordance
1	in-Barr virus latent membrane protein-1 oncogene deletion in post-transplantatio
2	   transglutaminases, involucrin, bcl-2 oncogene expression, apoptotic bodies, k
3	ession and prognostic value of c-erbB-2 oncogene product in human phaeochromocyt
4	ermal growth factor receptor, HER-2/neu oncogene expression, p53 tumor suppresso
5	eric mice, we further show that BCR-ABL oncogene does not require the endogenous
6	 associated with a complex of activated oncogene and inactivated tumor suppresso
7	locations of a number of human cellular oncogenes and the break points involved 
8	ies of genetic lesions in both dominant oncogenes and tumor suppressor genes are
9	The receptor encoded by the human C-MET oncogene is expressed in testicular tiss
10	mor DNA and amplification of the  N-myc oncogene within tumor tissue, since trea
11	berrations, fusion genes, expression of oncogenes, and monitoring of minimal res
12	cerization theories. The c-erbB-2 proto-oncogene has been amplified in many huma
13	tep to define the role of this putative oncogene in astrocytic tumour progressio
14	. These data indicate that active k-ras oncogene can induce TGF beta 1 resistanc
15	should be evaluated cautiously. Several oncogenes and cell receptors are normall
16	ption of the non structural E6 E7 viral oncogenes and have cytotoxic effects to